Global Health makes a decent debut, lists at 19% premium

New Delhi: Global Health made a decent debut on Dalal Street as the healthcare company got listed at Rs 401 on Wednesday, a premium of 19% over its issue price of Rs 336 on NSE.

The operator of the Medanta chain of hospitals debuted at a premium of 19% at Rs 398.15 over the given issue price on BSE.

Ahead of its listing on Dalal Street, shares of Global Health were trading at a premium of Rs 30-35 in the grey market, signalling a mild listing pop for investors.


Global Health is one of the largest private multi-speciality tertiary care providers operating in North and East India. It has a network of five hospitals under 'Medanta' brand in Gurugram, Indore, Ranchi, Patna and Lucknow.

The company's Rs 2,206-crore IPO was sold in the range of Rs 319-336 per share and received a mildly positive investor response, garnering over 9.5 times bids between November 03-07.

The quota reserved for qualified institutional buyers (QIBs) was subscribed 28.64 times while those reserved for non-institutional investors (NIIs) and retailers were subscribed 4.02 times and 88%, respectively.

For the year 2021-22, the company reported a profit after tax (PAT) of Rs 196.2 crore with a revenue of Rs Rs 2,205.82 crore. Its PAT stood at Rs 58.71 crore with total revenue at Rs 626.54 crore for the period ended June 30, 2022.